Fultium D3 800
Vitamin D is normally obtained primarily from sunlight acting on the skin. It is also consumed in the diet in oily fish and dairy products. Vitamin D deficiency develops when there is inadequate exposure to sunlight, such as in elderly people with reduced mobility or who are housebound, people who cover their skin when outdoors, or when there is a lack of the vitamin in the diet.
Vitamin D is needed for calcium to be absorbed from the gut, and deficiency can lead to low calcium levels and subsequent weakening of bones. This is known as osteomalacia. Vitamin D supplements correct vitamin D deficiency and improve calcium absorption from the gut. Vitamin D may be given in combination with calcium to treat osteomalacia and osteoporosis. Increasing vitamin D and calcium in the body helps to strengthen the bones.
- The prevention and treatment of vitamin D deficiency.
- As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.
- Fultium-D3 is indicated in adults, the elderly and adolescents.
Vitamin D deficiency or insufficiency in children over 12 years – 1 capsule daily depending on the severity of the disease and the patient's response to treatment. Should only be given under medical supervision.
Maize oil, refined Butylated hydroxytoluene (BHT) (E321) Capsule shell Glycerol (E422) Purified Water Brilliant Blue W.S (E133) Gelatin (E441)
- Vitamin D should be used with caution in patients with impairment of renal function and the effect on calcium and phosphate levels should be monitored. The risk of soft tissue calcification should be taken into account. In patients with severe renal insufficiency, vitamin D in the form of colecalciferol is not metabolised normally and other forms of vitamin D should be used (see section 4.3, contraindications).
- Caution is required in patients receiving treatment for cardiovascular disease (see Section 4.5 – cardiac glycosides including digitalis).
- Fultium-D3 should be prescribed with caution to patients suffering from sarcoidosis because of the risk of increased metabolism of vitamin D to its active form. These patients should be monitored with regard to the calcium content in serum and urine.
- Allowances should be made for vitamin D supplements from other sources.
- The need for additional calcium supplementation should be considered for individual patients. Calcium supplements should be given under close medical supervision.
- Medical supervision is required whilst on treatment to prevent hypercalcaemia.
- During long-term treatment with a daily dose exceeding 1,000 IU vitamin D the serum calcium values must be monitored.
- Fultium-D3 should not be given to children.